About

Andrew (Andy) Haigh, PhD MBA

Founder and President

Andy is an experienced technology and life sciences company operator and investor. He founded and built crossband.io to help make the venture financing process more efficient, accurate, and accessible. He is also an Entrepreneur-in-Residence with Genesys Capital, a biotechnology venture capital investment firm.

Previously, Andy was CEO of Adapsyn Biosciences, a venture-backed computational chemistry company, where he led development of the company’s genomics, machine learning, and data science platform to identify novel small molecule therapeutic candidates. Prior to Adapsyn, he was the second employee at Forbius, a biologic drug developer, where he established the company’s business development and finance functions prior to its sale to Bristol Myers Squibb for up to $1 billion.

Before transitioning to operational roles, Andy was an investor with Lumira Ventures, where he led or supported various follow-on financings and fundraising initiatives. He has served as a scientific reviewer for the NIH and on the board of BIOTECanada. He has a PhD from Dalhousie University and an MBA from the Ivey Business School at Western University, which he attended on full scholarship.